The minimally invasive procedure involves placing the Cardioband around the valve opening with the help of a catheter, secured with small anchors and tightened using a wire until the valve closes fully again. The Cardioband method gives leaky tricuspid valve patients an alternative to traditional open heart surgery using a heart-lung machine. Dr. Maisano was instrumental in developing the Cardioband.
“As tricuspid insufficiency often arises as a consequence of diseases of the mitral valve, open heart procedures are a risky surgical intervention,” said Dr. Maisano in a statement. “The Cardioband is a minimally invasive therapy which does not require the use of a heart-lung machine, reducing the impact on the patient and lowering the risk. Now, even patients previously thought to be inoperable can be treated.”
More articles on healthcare quality:
Wireless diagnostic device can detect flu strains within minutes
Feed a cold, starve a fever? Old saying may have truth behind it, new research finds
Birth control helps heal lungs damaged by influenza, finds study
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.